GB0215180D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB0215180D0
GB0215180D0 GB0215180A GB0215180A GB0215180D0 GB 0215180 D0 GB0215180 D0 GB 0215180D0 GB 0215180 A GB0215180 A GB 0215180A GB 0215180 A GB0215180 A GB 0215180A GB 0215180 D0 GB0215180 D0 GB 0215180D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0215180A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Technology Ltd
Original Assignee
Astex Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Technology Ltd filed Critical Astex Technology Ltd
Priority to GB0215180A priority Critical patent/GB0215180D0/en
Publication of GB0215180D0 publication Critical patent/GB0215180D0/en
Priority to PCT/GB2003/001507 priority patent/WO2003087087A2/en
Priority to EP03720680A priority patent/EP1495016A2/en
Priority to AU2003224257A priority patent/AU2003224257A1/en
Priority to JP2003584043A priority patent/JP2005526831A/en
Priority to US10/962,085 priority patent/US20050124620A1/en
Ceased legal-status Critical Current

Links

GB0215180A 2002-04-09 2002-06-29 Pharmaceutical compounds Ceased GB0215180D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB0215180A GB0215180D0 (en) 2002-06-29 2002-06-29 Pharmaceutical compounds
PCT/GB2003/001507 WO2003087087A2 (en) 2002-04-09 2003-04-08 Heterocyclic compounds and their use as modulators of p38 map kinase
EP03720680A EP1495016A2 (en) 2002-04-09 2003-04-08 Heterocyclic compounds and their use as modulators of p38 map kinase
AU2003224257A AU2003224257A1 (en) 2002-04-09 2003-04-08 Heterocyclic compounds and their use as modulators of p38 map kinase
JP2003584043A JP2005526831A (en) 2002-04-09 2003-04-08 Pharmaceutical compounds
US10/962,085 US20050124620A1 (en) 2002-04-09 2004-10-08 Pharmaceutical compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0215180A GB0215180D0 (en) 2002-06-29 2002-06-29 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB0215180D0 true GB0215180D0 (en) 2002-08-07

Family

ID=9939619

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0215180A Ceased GB0215180D0 (en) 2002-04-09 2002-06-29 Pharmaceutical compounds

Country Status (1)

Country Link
GB (1) GB0215180D0 (en)

Similar Documents

Publication Publication Date Title
GB0218625D0 (en) Pharmaceutical compounds
EG27104A (en) Pharmaceutical compounds
AU2003244650A8 (en) Medicinal compounds
GB0225540D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0225535D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
GB0315657D0 (en) Pharmaceutical compounds
GB0215775D0 (en) Pharmaceutical compounds
GB0308511D0 (en) Pharmaceutical compounds
GB0317315D0 (en) Pharmaceutical compounds
GB0206505D0 (en) Pharmaceutical combination
GB0313766D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
PL373409A1 (en) Pharmaceutical combination
GB0204392D0 (en) Pharmaceutical compound
GB0329617D0 (en) Pharmaceutical compounds
GB0310361D0 (en) Pharmaceutical compound
GB0208248D0 (en) Pharmaceutical compounds
GB0215939D0 (en) Pharmaceutical compounds
GB0230153D0 (en) Pharmaceutical compounds
GB0215180D0 (en) Pharmaceutical compounds
GB0212462D0 (en) Pharmaceutical compound
GB0212459D0 (en) Pharmaceutical compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)